22 Mar Experts call for TGA-approved rapid COVID-19 tests to be used in Australia
Our MD, John Kelly spoke to ABC News about the need for TGA-approved rapid COVID-19 tests to be used in Australia. Read Article Here...
Our MD, John Kelly spoke to ABC News about the need for TGA-approved rapid COVID-19 tests to be used in Australia. Read Article Here...
Stockhead lists Atomo Diagnostics as a stock to watch. Read Article Here...
The Motley Fool talks about Atomo Diagnostics’ share price rise. Read Article Here...
Harvard has begun to welcome back a limited number of students, faculty, academic personnel, and staff to our campus as conditions allow. They have deployed several strategies—including high-frequency viral testing for all community members who are authorized to have a regular presence on campus—to help...
An effective testing program is a crucial part of minimizing the spread of COVID-19 in a community, and testing innovations adopted by MIT are helping in-person activities to resume on campus. Read Article Here...
An effective testing program is a crucial part of minimizing the spread of COVID-19 in a community, and testing innovations developed by the University of Illinois Urbana-Champaign are helping in-person activities to resume on campus. Read Article Here...
Yale’s COVID-19 Screening Program consists of two components: testing and contact tracing. The program was designed to reduce the risk of outbreaks on campus and in the New Haven community, based on epidemiologic models and the best available data. Free viral testing is available to all...
Colleges are planning a wide range of COVID-19 testing strategies, ranging from frequent universal testing to no campus-based testing at all. Variation of approaches raises questions about equity. Different colleges are planning a wide range of COVID-19 testing approaches this fall. Some are planning on twice-weekly...
It’s a sign of how well Australia has handled the coronavirus pandemic that a single positive case in the community will make national headlines, while in many other countries thousands of people are dying from the disease every day. Our hotel quarantine system for returned travellers...
Researchers at NSF International and Novateur Ventures screen rapid-detection COVID-19 tests for clinical sensitivity/specificity, limit of detection and time to results After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection...
Dozens of public and private sector employers are now offering rapid testing to those without symptoms. Businesses and public sector organisations are joining a government scheme to test workers without symptoms who cannot work from home. Around 1 in 3 people who have coronavirus have no symptoms...
Big banks, including Deutsche Bank and Bank of America, are testing employees for COVID-19 before they step into the office. Some banks are offering their staff lab-based PCR tests, which are considered the most accurate way of detecting coronavirus, but they can cost around $US100 to...
The Motley Fool covers Atomo’s December quarterly report and how the company is positioning itself for growth in 2021. Read Article Here ...
The Market Herald reports on Atomo’s positive December 2020 quarterly report. Read Article Here ...
Our MD John Kelly sat down with Ausbiz to talk about Atomo’s strong growth, our solid progress with commercialising our rapid diagnostics tests and securing licensing deals with partners. Watch the interview here ...
Atomo was featured in a recent article by Biotech Dispatch regarding the TGA approval of Atomo’s rapid antigen COVID-19 test. Read Article Here ...
As WA and QLD take first steps to reopen borders, our CEO, John Kelly was asked to comment in the Australian Financial Review on how an antigen / antibody testing combo could help Australia to open up with more confidence. Read Article Here ...
Our MD, John Kelly was interviewed by Ausbiz about TGA approval for our COVID-19 rapid antigen test. Watch the Interview Here ...
Motley Fool talks about our share price gain following TGA approval of our COVID-19 rapid antigen test. Read the full article > ...
The Market Herald discusses the TGA approval for our COVID-19 rapid antigen test. Read the full article > ...
This Business News Australia discusses the benefits of our COVID-19 and the convenience of the 15-minute test. Read the full article > ...
An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India. Read the full article > ...
Our MD, John Kelly sat down with Ausbiz to discuss our rapid antigen test deal with Access Bio which will enable screening for COVID-19 acute infection and exposure at the same time. Watch the Video ...
An article by Biotech Dispatch on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India. Read the full article > ...
An article by Motley Fool on our expanded a partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India. Read the full article > ...
An article by Motley Fool on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India. Read the full article > ...
Atomo is mentioned in this Stockhead article as one of the Aussie companies involved in the efforts against COVID-19. Read the full article > ...
An article by Stockhead talks about our FY20 results and our COVID-19 antibody tests. Read the full article > ...
Medical diagnostics company Atomo Diagnostics (AT1) has seen its revenue jump nearly 900 per cent over FY20 as demand for COVID-19 antibody tests skyrockets. Read the full article > ...
An interview with Atomo MD, John Kelly on our FY20 results and strong uplift in revenues. Watch the full interview > ...